James, S. L., Bartlett, C. H., Robert, L., Morrow, C. J., Long, G. H., Cristofanilli, M., Sreenivasan, S. (2026). Prognostic value of
                    <i>ESR1</i>
                    mutation status in patients with metastatic breast cancer receiving second-line therapy: A real-world evidence study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e13140